AI assistant
AVECHO BIOTECHNOLOGY LIMITED — Director's Dealing 2021
May 30, 2021
64468_rns_2021-05-30_a472d8a2-5fb8-4f72-bc92-f5469aec99b2.pdf
Director's Dealing
Open in viewerOpens in your device viewer
Appendix 3Z Final Director’s Interest Notice
Rule 3.19A.3
Appendix 3Z
Final Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public. Introduced 30/9/2001.
Name of entity AVECHO BIOTECHNOLOGY LIMITED ABN 32 056 482 403
We (the entity) give ASX the following information under listing rule 3.19A.3 and as agent for the director for the purposes of section 205G of the Corporations Act.
| Name of director | David Segal |
|---|---|
| Date of last notice | 3 March 2017 |
| Date that director ceased to be director | 31 May 2021 |
Part 1 – Director’s relevant interests in securities of which the director is the registered holder In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.
Number & class of securities
11,795,920 Fully Paid Ordinary Shares (AVE) 1,500,000 unlisted Options (AVEAS)
- See chapter 19 for defined terms.
11/3/2002
Appendix 3Z Page 1
Appendix 3Z Final Director’s Interest Notice
Part 2 – Director’s relevant interests in securities of which the director is not the registered holder
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
| Name of holder & nature of interestNote: Provide details of the circumstances giving riseto the relevant interestMrs Danielle SegalDensville Pty Ltd | Number & class of securities6,200,000 Fully Paid Ordinary Shares (AVE)495,361 Fully Paid Ordinary Shares (AVE) |
|---|
Part 3 – Director’s interests in contracts
| Detail of contract | N/A |
|---|---|
| Nature of interest | N/A |
| Name of registered holder(if issued securities) | N/A |
| No. and class of securities to whichinterest relates | N/A |
- See chapter 19 for defined terms.
Appendix 3Z Page 2
11/3/2002